DEFINITIVE 14A

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

December 27, 2004

Period of Report

January 20, 2005

Accession Number

0001193125-04-219691

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →